KAZAN, RUSSIA - NOVEMBER 8, 2016: Technicians use microscopes at a laboratory at the Republic of Tatarstan Centre for Prevention and Control of AIDS and Infectious Diseases.
Yegor Aleyev/TASS (Photo by Yegor AleyevTASS via Getty Images) WASHINGTON - The U.S. Food and Drug Administration took a major step in the fight to end the HIV epidemic with the approval of the first injectable HIV prevention drug called Apretude.
Apretude offers an option to prevent HIV that does not involve taking a daily pill. According to the FDA, Apretude is given first to individuals as two injections allocated a month apart and then every two months after.